Pneumologia Pediátrica
Em jovens, a COVID-19 causa mais complicações do que a gripe; as fatalidades são raras.
9 Jun, 2021 | 09:54hEstudo original: 30-Day Outcomes of Children and Adolescents With COVID-19: An International Experience – Pediatrics
Condições médicas subjacentes associadas à COVID-19 grave em crianças – Os principais fatores de risco para hospitalização foram doenças crônicas e complexas, diabetes tipo 1 e obesidade.
8 Jun, 2021 | 10:31hComentários: Underlying illness, respiratory infection raise risk for severe COVID in kids – CIDRAP E COVID-19 in Children—Not Just Little Adults – JAMA Network Open
Comentário no Twitter
This cross-sectional study found a higher risk of severe #COVID19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. https://t.co/ifq1Ao0HKS
— JAMA Network Open (@JAMANetworkOpen) June 7, 2021
Sinopse | Atualizações das diretrizes de tratamento da asma pediátrica.
8 Jun, 2021 | 10:22hUpdates to the Pediatrics Asthma Management Guidelines – JAMA Pediatrics (gratuito por tempo limitado)
Estudo de coorte mostrou boa recuperação na maioria das crianças 6 meses após síndrome multissistêmica inflamatória pediátrica (pediatric inflammatory multisystem syndrome – PIMS-TS) associada ao SARS-CoV-2.
3 Jun, 2021 | 10:07hComentário: Most severe effects of MIS-C in children typically resolve within six months, new research suggests – CNN E Children who developed a rare inflammation disease after COVID-19 are mostly better after 6 months, but some still suffer fatigue and anxiety, a small UK study found – Insider E Most severe effects of PIMS-TS resolved at six months – HealthDay
Comentário no Twitter
New Research—A study of 46 patients with #PIMSTS found that most symptoms were resolved after 6 months, but fatigue, difficulty exercising, and emotional difficulties persisted in some childrenhttps://t.co/mHz3D8a11d #COVID19 @GreatOrmondSt @KarynMoshal pic.twitter.com/PJCxGGmJNo
— The Lancet Child & Adolescent Health (@LancetChildAdol) May 24, 2021
Estudo randomizado: Para atingir a cura clínica em torno de 28 dias em crianças com bronquite bacteriana prolongada, um curso de 4 semanas de amoxicilina-clavulanato não é melhor do que um curso de 2 semanas.
31 Mai, 2021 | 12:03hComentário: Four weeks of antibiotics for kids’ chronic cough no better than 2, study finds – CIDRAP
Comentário no Twitter
NEW Research—4 weeks of amoxicillin–clavulanate for children with chronic wet cough and suspected PBB confers little advantage vs 2 weeks in achieving clinical cure by 28 days
RCT from Tom Ruffles & colleagues https://t.co/77w08dZ20z pic.twitter.com/LYgOeJbDX8
— The Lancet Respiratory Medicine (@LancetRespirMed) May 26, 2021
Diretrizes de práticas clínicas da ERS para o diagnóstico da asma em crianças de 5 a 16 anos.
20 Mai, 2021 | 10:45hEstudo de coorte com 12.306 pacientes pediátricos de COVID-19 mostra que somente 16,5% deles apresentaram sintomas respiratórios típicos (tosse, dispneia); 13,9% tiveram sintomas GI; 8,1% tiveram sintomas dermatológicos (rash); 4,8% tiveram sintomas neurológicos (cefaleia) e 1,8% teve outros sintomas inespecíficos (febre, desconforto, mialgia, artralgia e distúrbios de olfato e paladar).
14 Mai, 2021 | 10:16hComentário: COVID-19: Majority of infected children may not show typical symptoms – Nature Publishing Group
Comentário no Twitter
A retrospective cohort study of 12,306 pediatric COVID-19 patients
📍5% require hospitalization
📍18% of these require critical care
📍4% of these require ventilation
https://t.co/X6MTdS8D1i— Rick MaskDonald MD 🚴♂️🏄🏻🎾 (@Kidsdoc1Rick) May 13, 2021
Estudo randomizado: Tezepelumabe pode reduzir as exacerbações em adultos e adolescentes com asma grave e não controlada.
14 Mai, 2021 | 09:57hComentário: New drug shows promise against tough-to-manage asthma – MedicalXpress